Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
Published: May 2022 - Pages: 148
Tumor Necrosis Factor Ligand Superfamily Member 10 (Apo 2 Ligand or TNF Related Apoptosis Inducing Ligand or Protein TRA...
Published: May 2022 - Pages: 36
Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
Published: May 2022 - Pages: 147
Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 46
Relapsing Remitting Multiple Sclerosis (RRMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
Published: May 2022 - Pages: 86
Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC...
Published: May 2022 - Pages: 35
Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 250
Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) Drugs in Development by Therapy Areas and Indications, Stages, M...
Published: May 2022 - Pages: 35
Respiratory Depression (Hypoventilation) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 37
Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) Drugs ...
Published: May 2022 - Pages: 35
Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 91
Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) Drugs in Development by Therapy Area...
Published: May 2022 - Pages: 35
Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 69
Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 76
Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 48
Werner Syndrome ATP Dependent Helicase?(DNA Helicase RecQ Like Type 3 or Exonuclease WRN or RecQ Protein Like 2 or WRN o...
Published: May 2022 - Pages: 38
Zika Virus Envelope Protein (E) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type a...
Published: May 2022 - Pages: 36
Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 47
Seasonal Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 92
Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) Drugs in Development by Therapy Areas and ...
Published: May 2022 - Pages: 35
